Oxbridge Re (NASDAQ:OXBR) Earns Sell (D-) Rating from Weiss Ratings

Oxbridge Re (NASDAQ:OXBR)‘s stock had its “sell (d-)” rating reaffirmed by Weiss Ratings in a report released on Saturday,Weiss Ratings reports.

Oxbridge Re Price Performance

OXBR opened at $1.71 on Friday. The business has a 50 day simple moving average of $1.98 and a 200-day simple moving average of $1.85. The stock has a market capitalization of $13.06 million, a P/E ratio of -4.17 and a beta of 1.99. Oxbridge Re has a 12 month low of $1.27 and a 12 month high of $5.81.

Oxbridge Re (NASDAQ:OXBR) last posted its quarterly earnings results on Thursday, August 14th. The insurance provider reported ($0.25) EPS for the quarter, missing the consensus estimate of $0.03 by ($0.28). The business had revenue of $0.66 million during the quarter, compared to analyst estimates of $1.11 million. Oxbridge Re had a negative net margin of 151.89% and a negative return on equity of 59.48%.

Hedge Funds Weigh In On Oxbridge Re

An institutional investor recently bought a new position in Oxbridge Re stock. Armistice Capital LLC acquired a new position in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 622,165 shares of the insurance provider’s stock, valued at approximately $1,176,000. Armistice Capital LLC owned about 8.36% of Oxbridge Re as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 5.64% of the company’s stock.

Oxbridge Re Company Profile

Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology.